A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
miRagen Therapeutics, Inc.
miRagen Therapeutics, Inc.